Index of microcirculatory resistance as a tool to characterize microvascular obstruction and to predict infarct size regression in patients with STEMI undergoing primary …
GL De Maria, M Alkhalil, M Wolfrum, G Fahrni… - JACC: Cardiovascular …, 2019 - jacc.org
GL De Maria, M Alkhalil, M Wolfrum, G Fahrni, A Borlotti, L Gaughran, S Dawkins…
JACC: Cardiovascular Imaging, 2019•jacc.orgObjectives: This study aimed to compare the value of the index of microcirculatory resistance
(IMR) and microvascular obstruction (MVO) measured by cardiac magnetic resonance
(CMR) in patients treated for and recovering from ST-segment elevation myocardial
infarction. Background: IMR can identify patients with microvascular dysfunction acutely after
primary percutaneous coronary intervention (pPCI), and a threshold of> 40 has been shown
to be associated with an adverse clinical outcome. Similarly, MVO is recognized as an …
(IMR) and microvascular obstruction (MVO) measured by cardiac magnetic resonance
(CMR) in patients treated for and recovering from ST-segment elevation myocardial
infarction. Background: IMR can identify patients with microvascular dysfunction acutely after
primary percutaneous coronary intervention (pPCI), and a threshold of> 40 has been shown
to be associated with an adverse clinical outcome. Similarly, MVO is recognized as an …
Objectives
This study aimed to compare the value of the index of microcirculatory resistance (IMR) and microvascular obstruction (MVO) measured by cardiac magnetic resonance (CMR) in patients treated for and recovering from ST-segment elevation myocardial infarction.
Background
IMR can identify patients with microvascular dysfunction acutely after primary percutaneous coronary intervention (pPCI), and a threshold of >40 has been shown to be associated with an adverse clinical outcome. Similarly, MVO is recognized as an adverse feature in patients with ST-segment elevation myocardial infarction. Even though both IMR and MVO reflect coronary microvascular status, the interaction between these 2 parameters is uncertain.
Methods
A total of 110 patients treated with pPCI were included, and IMR was measured immediately at completion of pPCI. Infarct size (IS) as a percentage of left ventricular mass was quantified at 48 h (38.4 ± 12.0 h) and 6 months (194.0 ± 20.0 days) using CMR. MVO was identified and quantified at 48 h by CMR.
Results
Overall, a discordance between IMR and MVO was observed in 36.7% of cases, with 31 patients having MVO and IMR ≤40. Compared with patients with MVO and IMR ≤40, patients with both MVO and IMR >40 had an 11.9-fold increased risk of final IS >25% at 6 months (p = 0.001). Patients with MVO and IMR ≤40 had a significantly smaller IS at 6 months (p = 0.001), with significant regression in IS over time (34.4% [interquartile range (IQR): 27.3% to 41.0%] vs. 22.3% [IQR: 16.0% to 30.0%]; p = 0.001).
Conclusions
Discordant prognostic information was obtained from IMR and MVO in nearly one-third of cases; however, IMR can be helpful in grading the degree and severity of MVO.
jacc.org
以上显示的是最相近的搜索结果。 查看全部搜索结果